A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project

被引：0

作者：

Diana Molino

Christine Durier

Anne Radenne

Corinne Desaint

Jacques Ropers

Soizic Courcier

Louis Victorien Vieillard

Claire Rekacewicz

Beatrice Parfait

Victor Appay

Frédéric Batteux

Emmanuel Barillot

Michel Cogné

Béhazine Combadière

Christiane S. Eberhardt

Guy Gorochov

Philippe Hupé

Laetitia Ninove

Stéphane Paul

Isabelle Pellegrin

Sylvie van der Werf

Maeva Lefebvre

Elisabeth Botelho-Nevers

Inmaculada Ortega-Perez

Marie Jaspard

Samba Sow

Jean Daniel Lelièvre

Xavier de Lamballerie

Marie Paule Kieny

Eric Tartour

Odile Launay

机构：

[1] Université Paris Cité,Laboratory of Immunology—Research Unit INSERM U 1236, B cell Ig Remodelling Singularities (BIGRES), Faculty of Medicine

[2] National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur,Centre d’Immunologie et des Maladies Infectieuses–Paris (Cimi

[3] Innovative Clinical Research Network in Vaccinology (I-REIVAC),Paris), INSERM U1135

[4] Assistance Publique-Hôpitaux de Paris (AP-HP),undefined

[5] Hôpital Cochin,undefined

[6] INSERM SC10-US019,undefined

[7] AP-HP,undefined

[8] Hôpitaux Universitaires Pitié Salpêtrière–Charles Foix,undefined

[9] Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière,undefined

[10] AP-HP,undefined

[11] Hôpital Cochin,undefined

[12] Fédération des Centres de Ressources Biologiques–Plateforme de Ressources Biologiques Centre de Ressources Biologique Cochin,undefined

[13] Centre Hospitalier Universitaire (CHU) Bordeaux,undefined

[14] Laboratory of Immunology and Immunogenetics,undefined

[15] Université de Bordeaux,undefined

[16] Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 5164,undefined

[17] INSERM ERL 1303,undefined

[18] ImmunoConcEpT,undefined

[19] AP-HP,undefined

[20] Hôpital Cochin,undefined

[21] Service d’Immunologie Biologique et Plateforme d’Immunomonitoring Vaccinal,undefined

[22] Institut Curie,undefined

[23] PSL Research University–INSERM U900–MINES ParisTech,undefined

[24] PSL,undefined

[25] French Blood Center (EFS Bretagne) & University Hospital,undefined

[26] Sorbonne Université,undefined

[27] University of Geneva,undefined

[28] Faculty of Medicine,undefined

[29] Division of General Pediatrics,undefined

[30] Department of Woman,undefined

[31] Child and Adolescent Medicine and Center for Vaccinology,undefined

[32] Sorbonne Université,undefined

[33] INSERM,undefined

[34] Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris),undefined

[35] Département d’Immunologie,undefined

[36] AP-HP,undefined

[37] Hôpital Pitié-Salpêtrière,undefined

[38] CNRS,undefined

[39] UMR 144,undefined

[40] Aix Marseille Université,undefined

[41] Research Institute for Sustainable Development (IRD) 190,undefined

[42] INSERM 1207,undefined

[43] IHU Méditerranée Infection,undefined

[44] Unité des Virus Émergents,undefined

[45] INSERM,undefined

[46] U1111,undefined

[47] CNRS,undefined

[48] UMR 530,undefined

[49] Immunology and Immunomonitoring Laboratory,undefined

[50] iBiothera,undefined

来源：

Nature Medicine | 2022年 / 28卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：882 / 884

页数：2

共 50 条

[1] A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project
Molino, Diana
Durier, Christine
Radenne, Anne
Desaint, Corinne
Ropers, Jacques
Courcier, Soizic
Vieillard, Louis Victorien
Rekacewicz, Claire
Parfait, Beatrice
Appay, Victor
Batteux, Frederic
Barillot, Emmanuel
Cogne, Michel
Combadiere, Behazine
Eberhardt, Christiane S.
Gorochov, Guy
Hupe, Philippe
Ninove, Laetitia
Paul, Stephane
Pellegrin, Isabelle
van der Werf, Sylvie
Lefebvre, Maeva
Botelho-Nevers, Elisabeth
Ortega-Perez, Inmaculada
Jaspard, Marie
Sow, Samba
Lelievre, Jean Daniel
de Lamballerie, Xavier
Kieny, Marie Paule
Tartour, Eric
Launay, Odile
[J]. NATURE MEDICINE, 2022, 28 (05) : 882 - 884
[2] Platforms Exploited for SARS-CoV-2 Vaccine Development
Mathew, Shilu
Faheem, Muhammed
Hassain, Neeraja A.
Benslimane, Fatiha M.
Al Thani, Asmaa A.
Zaraket, Hassan
Yassine, Hadi M.
[J]. VACCINES, 2021, 9 (01) : 1 - 24
[3] Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Samir Andrade Mendonça
Reka Lorincz
Paul Boucher
David T. Curiel
[J]. npj Vaccines, 6
[4] Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Mendonca, Samir Andrade
Lorincz, Reka
Boucher, Paul
Curiel, David T.
[J]. NPJ VACCINES, 2021, 6 (01)
[5] New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
Ura, Takehiro
Yamashita, Akio
Mizuki, Nobuhisa
Okuda, Kenji
Shimada, Masaru
[J]. VACCINE, 2021, 39 (02) : 197 - 201
[6] mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
Ilyichev, A. A.
Orlova, L. A.
Sharabrin, S., V
Karpenko, L., I
[J]. VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2020, 24 (07): : 802 - 807
[7] Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants
Chatterjee, Bhaswati
Thakur, Suman S.
[J]. EXPERT REVIEW OF VACCINES, 2022, 21 (01) : 47 - 67
[8] SARS-CoV-2 mucosal vaccine
Houston, Stephanie
[J]. NATURE IMMUNOLOGY, 2023, 24 (01) : 1 - 1
[9] A VACCINE AGAINST SARS-COV-2
Passi, Gouri Rao
[J]. INDIAN PEDIATRICS, 2020, 57 (06) : 593 - 593
[10] Inactivated vaccine for SARS-CoV-2
Emma Risson
[J]. Nature Reviews Immunology, 2020, 20 : 353 - 353

← 1 2 3 4 5 →